Rapid Dose Therapeutics Corp. (CSE: DOSE) (OTCQB: RDTCF) Leading $5.21B Oral Thin Film Market Growth – More Stocks InsideThe oral thin film drug delivery market is entering a high-growth phase, with industry forecasts projecting expansion from $3.30 billion in 2025 to $5.21 billion by 2030, representing a 9.56% CAGR . As demand accelerates for faster, more efficient drug delivery systems , companies positioned at the forefront of this innovation—such as Rapid Dose Therapeutics (CSE: DOSE) (OTCQB: RDTCF)—are increasingly drawing investor attention.
Rosen Law Firm Encourages GMEX Robotics Corp. Investors to Inquire About Securities Class Action Investigation – GMEX
Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GMEX Robotics Corp. (
NASDAQ: GMEX) resulting from allegations that GMEX may have issued materially misleading business information to the investing public.
ADM Endeavors (OTCQB: ADMQ) Gains Momentum as $13M Facility Expansion Signals Scalable Growth PhaseADM Endeavors (OTCQB: ADMQ) is beginning to attract increased investor attention following a 67% move off its March 2026 levels, as the company enters what could be a defining phase of operational scale driven by infrastructure expansion, brand growth, and entry into larger addressable markets.
